共 9 条
[1]
Usefulness of station drugs in protecting against atrial fibrillation in patients with CorOnary artery disease. Xu YY,Jabbour S,Goldberg k,et al. The American Journal of Cardiology . 2003
[2]
Simvastatin exerts both anti-imflammatory and cardioprotective.Effects in apolipoprotein E-deficient mice. Scalia R,Gooszen ME,Jones SP,et al. Circulation . 2001
[3]
Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Mihm MJ,Yu F,Cames CA,et al. Circulation . 2001
[4]
Inflammation as a risk factor for atrial fibrillation. Aviles RJ,Martin DO,Hassen CA,et al. Circulation . 2003
[5]
Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Frustaci A,Chimenti C,Bellocci F,et al. Circulation . 1997
[6]
C-reactive protein elevation in patients with atrial arrhythmias. Chung MK,Martin DO,Sprecher D,et al. Circulation . 2001
[7]
Simvastatin preserves the ischemic-reperfused myocardium in normocholerterolemic rat hearts. Lefer AM,Campbell B,Shin YK,et al. Circulation . 1999
[8]
Promotion of atrial fibrillation by heart failure in dog: atrial remodeling of a different sort. Li D,Fareh S,Leung TK,et al. Circulation . 1999
[9]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24